Objectives
Urinary tract infections (UTIs) in children are rapidly increasing worldwide and are commonly caused by extensively drug-resistant bacteria. This study determines the prevalence of UTIs in paediatric patients and evaluates the pattern of extensively drug-resistance in
Escherichia coli
and
Klebsiella
pneumoniae
strains isolated from paediatric UTI patients.
Methods
Uropathogenic bacterial strains were isolated from paediatric patients with UTIs admitted to the Institute of Child Health, Lahore, Pakistan. Strains of both
E. coli
and
K. pneumoniae
were identified using biochemical characterisation and subjected to antibiotic susceptibility assays for 21 common antimicrobial drugs in order to determine their extensively drug-resistant profile.
Results
We isolated 63
E. coli
and 37
K. pneumoniae
strains from 130 paediatric patients with UTIs over a period of six months. The antibiotic susceptibility assays showed that both the
E. coli
and
K. pneumoniae
strains exhibited a high degree of resistance against co-amoxiclav, cefuroxime, cefixime, cefotaxime, ceftazidime, ceftriaxone, ciprofloxacin, nalidixic acid, norfloxacin, pepedemic acid, and co-trimoxazole. However, several of the antimicrobial agents, including polymyxin B, colistin sulphate, chloramphenicol, nitrofurantoin, and fosfomycin, were found to retain their antimicrobial activities against both pathogens. The five highest antibiotic resistant strains were identified as
E. coli
strains ZK9, ZK40, and ZK60 and
K. pneumoniae
ZK32 and ZK89 using 16S rRNA gene sequencing.
Conclusion
Our study demonstrates that
E. coli
and
K. pneumonia
are the dominant extensively drug-resistant uropathogenic bacteria in community-acquired UTIs in our cohort. These uropathogens were found to be resistant to the majority of the routinely-used classes of β-lactams, pyridopyrimidines, quinolones, and fluoroquinolone antibiotics, and these findings may be useful for clinicians in their treatment of paediatric UTIs.